Dr. Rugo on the Advances in the Treatment of HER2-Positive Breast Cancer

New Directions in the Treatment of Breast Cancer: Bringing Biology to the Clinic and BackПодробнее

The 2022 OncoAlert Colloquium DAY 1: Breast CancerПодробнее

Dr. Hope Rugo – ESMO 2022 – Exploring the latest trial data & advances in breast cancer treatmentsПодробнее

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment ArsenalПодробнее

2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment ApproachesПодробнее

The OncoAlert Colloquium Day 3 Breast CancerПодробнее

Hope Rugo, MD: Advances and Challenges In the Treatment of Metastatic Breast CancerПодробнее

UCSF Bay Area Breast Cancer Forum: Updates from ESMO 2020 2020: New Developments in TreatmentПодробнее

Dr. Rugo on PI3K and mTOR Inhibitors for the Treatment of Breast CancerПодробнее

“Key Breakthroughs in the Field of Breast Cancer Treatment” by Dr. Hope RugoПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Hope S. RugoПодробнее

HER2 In Breast Cancer: Testing Guidelines and New Treatment ApproachesПодробнее

Dr. Tripathy on Standard and Emerging Treatment Advances for HER2+ Breast CancerПодробнее